Marcel Doerflinger

Marcel Doerflinger

Auto-generated profile, based on publicly available information

Marcel Doerflinger

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TKTheresa Klemm
Theresa Klemm
GEGregor Ebert
Gregor Ebert
DCDale J Calleja
Dale J Calleja
CACody C Allison
Cody C Allison
LRLachlan W Richardson
Lachlan W Richardson
DKDavid Komander
David Komander
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 September 2020 in Immunity
Verified
Journal Article
Open access
MDMarcel Doerflinger
Marcel Doerflinger
YDYexuan Deng
Yexuan Deng
PWPaul Whitney
Paul Whitney
RSRanja Salvamoser
Ranja Salvamoser
SESven Engel
Sven Engel
MHMarco Herold
Marco Herold
Programmed cell death contributes to host defense against pathogens. To investigate the relative importance of pyroptosis, necroptosis, and apoptosis during Salmonella infection, we infected mice and macrophages deficient for diverse combinations of caspases-1, -11, -12, and -8 and receptor interacting serine/threonine kinase 3 (RIPK3). Loss of pyroptosis, caspase-8-driven apoptosis, or necroptosis had minor impact on Salmonella control. However, combined deficiency of these cell death pathways caused loss of bacterial control in mice and their macrophages, demonstrating that host defense can employ varying components of several cell death pathways to limit intracellular infections. This flexible use of distinct cell death pathways involved extensive cross-talk between initiators and effectors of pyroptosis and apoptosis, where initiator caspases-1 and -8 also functioned as executioners when all known effectors of cell death were absent. These findings uncover a highly coordinated and flexible cell death system with in-built fail-safe processes that protect the host from intracellular infections.

23 April 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PPPhillip Pymm
Phillip Pymm
AAAmy Adair
Amy Adair
LCLi-Jin Chan
Li-Jin Chan
JCJames P. Cooney
James P. Cooney
FMFrancesca L. Mordant
Francesca L. Mordant
WTWai-Hong Tham
Wai-Hong Tham
Neutralizing antibodies are important for immunity against SARS-CoV-2 and as therapeutics for the prevention and treatment of COVID-19. Here, we identified high-affinity nanobodies from alpacas immunized with coronavirus spike and receptor-binding domains (RBD) that disrupted RBD engagement with the human receptor angiotensin-converting enzyme 2 (ACE2) and potently neutralized SARS-CoV-2. Epitope mapping, X-ray crystallography, and cryo-electron microscopy revealed two distinct antigenic sites and showed two neutralizing nanobodies from different epitope classes bound simultaneously to the spike trimer. Nanobody-Fc fusions of the four most potent nanobodies blocked ACE2 engagement with RBD variants present in human populations and potently neutralized both wild-type SARS-CoV-2 and the N501Y D614G variant at concentrations as low as 0.1 nM. Prophylactic administration of either single nanobody-Fc or as mixtures reduced viral loads by up to 104-fold in mice infected with the N501Y D614G SARS-CoV-2 virus. These results suggest a role for nanobody-Fc fusions as prophylactic agents against SARS-CoV-2. Significance Neutralizing antibodies are important for immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and as therapeutics for the prevention and treatment of COVID-19. We identified high-affinity nanobodies against SARS-CoV-2 receptor-binding domain and found that nanobody cocktails consisting of two noncompeting nanobodies were able to block ACE2 engagement with RBD variants present in human populations and potently neutralize both wild-type SARS-CoV-2 and the N501Y D614G variant at low concentrations. Prophylactic administration of nanobody cocktails reduced viral loads in mice infected with the N501Y D614G SARS-CoV-2 virus, showing that nanobody cocktails are useful as prophylactic agents against SARS-CoV-2.

26 January 2015 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
MDMarcel Doerflinger
Marcel Doerflinger
JGJason A. Glab
Jason A. Glab
HPHamsa Puthalakath
Hamsa Puthalakath

15 December 2017 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
MSMichael D. Stutz
Michael D. Stutz
MCMichelle P. Clark
Michelle P. Clark
MDMarcel Doerflinger
Marcel Doerflinger
MPMarc Pellegrini
Marc Pellegrini
The ability of Mycobacterium tuberculosis to cause disease hinges upon successfully thwarting the innate defenses of the macrophage host cell. The pathogen's trump card is its armory of virulence factors that throw normal host cell signaling into disarray. This process of subverting the macrophage begins upon entry into the cell, when M. tuberculosis actively inhibits the fusion of the bacilli-laden phagosomes with lysosomes. The pathogen then modulates an array of host signal transduction pathways, which dampens the macrophage's host-protective cytokine response, while simultaneously adapting host cell metabolism to stimulate lipid body accumulation. Mycobacterium tuberculosis also renovates the surface of its innate host cells by altering the expression of key molecules required for full activation of the adaptive immune response. Finally, the pathogen coordinates its exit from the host cell by shifting the balance from the host-protective apoptotic cell death program toward a lytic form of host cell death. Thus, M. tuberculosis exploits its extensive repertoire of virulence factors in order to orchestrate the infection process to facilitate its growth, dissemination, and entry into latency. This review offers critical insights into the most recent advances in our knowledge of how M. tuberculosis manipulates host cell signaling. An appreciation of such interactions between the pathogen and host is critical for guiding novel therapies and understanding the factors that lead to the development of active disease in only a subset of exposed individuals.

14 April 2017 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
JGJason A Glab
Jason A Glab
MDMarcel Doerflinger
Marcel Doerflinger
CNChristina Nedeva
Christina Nedeva
IJIrvin Jose
Irvin Jose
GMGeorge W Mbogo
George W Mbogo
HPHamsa Puthalakath
Hamsa Puthalakath
The endoplasmic reticulum (ER) stress response constitutes cellular reactions triggered by a wide variety of stimuli that disturb folding of proteins, often leading to apoptosis. ER stress-induced apoptotic cell death is thought to be an important contributor to many human pathological conditions. The molecular mechanism of this apoptosis process has been highly controversial with both the receptor and the mitochondrial pathways being implicated. Using knockout mouse models and RNAi-mediated gene silencing in cell lines, our group and others had demonstrated the importance of the mitochondrial apoptotic pathway in ER stress-induced cell death, particularly the role of the pro-apoptotic BH3-only BCL-2 family members, BIM and PUMA. However, a recent report suggested a central role for the death receptor, DR5, activated in a ligand-independent manner, and the initiator caspase, caspase-8, in ER stress-induced cell death. This prompted us to re-visit our previous observations and attempt to reproduce the newly published findings. Here we report that the mitochondrial apoptotic pathway, activated by BH3-only proteins, is essential for ER stress-induced cell death and that, in contrast to the previous report, DR5 as well as caspase-8 are not required for this process.